Fudan University Shanghai Cancer Center, Shanghai,
Fudan University Shanghai Cancer Center, Shanghai,
Shanghai, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Vebreltinib for Neoadjuvant in METex 14 Skipping Mutant Stage IIA-IIIB (N2) Non-small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Not yet recruiting | Phase 2 | 2025-09-05 | NCT07156604 |